Nycomed Pharma Private Limited
About Nycomed Pharma Private Limited
Data last updated:
Nycomed Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 09 May 2003.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2003PTC148545.
The company has an authorised share capital of ₹50 Cr and a paid-up capital of ₹9.72 Cr. It is led by directors including Stefan Kollmann and Felix Reutter.
Its last annual general meeting (AGM) was held on 30 August 2013, and its latest financial statements are for the year ended 31 March 2013. The registered office is at 2/E Court Chambers 2nd Floor 35 New Marine Lines, Mumbai, Maharashtra, India – 400020.
Court records list 2 cases involving the company, including 2 filed by the company.
Company details
CIN history
Nycomed Pharma has one previous CIN (Corporate Identification Number): U24239MH2004PTC148545. The current CIN is U24239MH2003PTC148545, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239MH2003PTC148545 | Current |
| U24239MH2004PTC148545 | Previous |
Contact details
Nycomed Pharma Private Limited's registered office is in Mumbai, Maharashtra.
- Registered Address2/E Court Chambers 2nd Floor 35 New Marine Lines, Mumbai, Maharashtra, India – 400020
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Nycomed Pharma Private Limited
FY 2013 filings availableFinancial Statement Summary
| Metrics | FY 2012-13 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2012-13 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Nycomed Pharma Private Limited, buy the company report.
Board of directors of Nycomed Pharma Private Limited
Nycomed Pharma has 3 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Stefan Kollmann | Director | 29 Mar 2013 | 13 Years 6 Months | As last reported |
| Felix Reutter | Director | 29 Mar 2013 | 13 Years 6 Months | As last reported |
| Sham Shridhar Nikam | Director | 29 Mar 2013 | 13 Years 6 Months | As last reported |
Legal cases
Nycomed Pharma Private Limited has 2 court cases on record: 2 filed by Nycomed Pharma. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (CSD) | Filed by the company | Disposed |
| Bombay High Court | Court case (CSP) | Filed by the company | Disposed |
To see the full case history of Nycomed Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nycomed Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Nycomed Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Nycomed Pharma Private Limited has 16 board changes on record since 2008: 3 appointments and 13 cessations. The latest: Felix Reutter ceased to be Additional Director on 30 Aug 2013.
7 earlier events are in the company report.
Frequently asked questions
Nycomed Pharma is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.
Nycomed Pharma is a company under liquidation, formerly operating as a private limited company based in Mumbai, Maharashtra, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 09 May 2003 and is registered under CIN U24239MH2003PTC148545. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Nycomed Pharma has 3 current directors:
- Stefan Kollmann - Director
- Felix Reutter - Director
- Sham Shridhar Nikam - Director
The latest financial statements of Nycomed Pharma on record with the MCA are for the year ended 31 March 2013. Its last annual general meeting was held on 30 August 2013. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Nycomed Pharma is U24239MH2003PTC148545. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nycomed Pharma has 2 court cases on record: 2 filed by the company.
Nycomed Pharma was incorporated on 09 May 2003. It is registered with the Registrar of Companies, Mumbai.
Felix Reutter ceased to be Additional Director on 30 Aug 2013. Sham Shridhar Nikam ceased to be Additional Director on 30 Aug 2013. Stefan Kollmann ceased to be Additional Director on 30 Aug 2013. Nycomed Pharma has 16 board changes on record in total.
The registered office of Nycomed Pharma is at 2E Court Chambers 2nd Floor 35 New Marine Lines, Mumbai, Maharashtra, India – 400020.
Nycomed Pharma operates in the pharma industry, in the pharma contract r and d segment.